PP2A activation alone and in combination with cisplatin decreases cell growth and tumor formation in human HuH6 hepatoblastoma cells

Despite an increase in incidence, treatments for hepatoblastoma remain virtually unchanged for the past 20 years, emphasizing the need for novel therapeutics. FTY720 (fingolimod) is an immunomodulator approved for use in multiple sclerosis in children that has been demonstrated to have anti-cancer p...

Descripción completa

Detalles Bibliográficos
Autores principales: Stafman, Laura L., Williams, Adele P., Marayati, Raoud, Aye, Jamie M., Stewart, Jerry E., Mroczek-Musulman, Elizabeth, Beierle, Elizabeth A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457532/
https://www.ncbi.nlm.nih.gov/pubmed/30969990
http://dx.doi.org/10.1371/journal.pone.0214469

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457532/
https://www.ncbi.nlm.nih.gov/pubmed/30969990
http://dx.doi.org/10.1371/journal.pone.0214469

Ejemplares similares